Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Automated Breast Ultrasound Market Size & Growth Forecast 2027–2036, By Segments (Product, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 13799| Published Date: Sep-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Automated Breast Ultrasound Market size stood at USD 2.6 billion in 2026 and is predicted to grow at a 12.92% CAGR from 2027 to 2036, exceeding USD 8.76 billion by 2036. The industry revenue for 2027 is calculated at USD 2.88 billion.

Base Year Value (2026)
USD 2.6 billion
CAGR (2027-2036)
12.92%
Forecast Year Value (2036)
USD 8.76 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Automated Breast Ultrasound Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads due to advanced breast imaging infrastructure, widespread diagnostic system availability, and routine integration of automated ultrasound into established clinical screening workflows.
  • Asia Pacific is expanding at 15.01% CAGR, driven by broader access to imaging systems and increasing adoption of scalable, workflow-efficient breast screening technologies across healthcare facilities.

Segment Momentum

  • ABUS leads with 61.01% share due to strong clinical familiarity, integration into diagnostic workflows, and standardized imaging that reduces operator dependence in high-volume breast screening environments.
  • Automated Breast Volume Scanner is growing faster due to demand for more comprehensive volumetric breast imaging, offering detailed tissue visualization and aligning with efficient, structured diagnostic interpretation needs.

Market Expansion Drivers

  • Rising global breast cancer prevalence increasing demand for early-stage diagnostic imaging solutions.
  • Government awareness programs and cancer screening initiatives accelerating automated ultrasound adoption.
  • Advancements in wearable and AI-enabled breast imaging technologies improving diagnostic accuracy.

Leading Market Participants

  • Leading players in the automated breast ultrasound market include GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Hologic, Inc. (United States), Delphinus Medical Technologies, Inc. (United States), SuperSonic Imagine SA (France), TELEMED Medical Systems S.r.l. (Italy), Samsung Medison Co., Ltd. (South Korea).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 2.6 billion
  • 2027 Estimated Market Size: USD 2.88 billion.
  • Projected Market Size: USD 8.76 billion by 2036
  • Growth Forecast: 12.92% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Automated Breast Ultrasound (ABUS) (Product) | Hospital (End Use)
  • Emerging Opportunity Segment: Automated Breast Volume Scanner (Product) | Diagnostics Imaging Laboratories (End Use)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising global breast cancer prevalence increasing demand for early-stage diagnostic imaging solutions

The rising incidence of breast cancer is creating greater demand for accessible and effective diagnostic imaging, and the automated breast ultrasound market will benefit from the growing emphasis on detecting abnormalities at earlier stages. Automated ultrasound systems can support breast examination by providing consistent imaging of breast tissue and helping identify lesions that may require further clinical evaluation, particularly in screening environments where imaging efficiency and reproducibility are important. Increasing awareness of the benefits associated with early diagnosis is also encouraging healthcare providers to strengthen breast cancer screening pathways, while the need for complementary imaging options can support broader utilization of automated ultrasound technologies among diagnostic centers and hospitals.

Government awareness programs and cancer screening initiatives accelerating automated ultrasound adoption

Public health campaigns and organized cancer screening initiatives are expanding awareness of routine breast examinations and encouraging healthcare systems to improve access to diagnostic services. Within the automated breast ultrasound market, these initiatives can accelerate adoption by increasing screening volumes and creating demand for imaging technologies capable of supporting standardized and efficient examinations. Government-backed programs can also encourage investments in diagnostic infrastructure, particularly where healthcare authorities are seeking to improve early detection and extend screening services to underserved populations. Greater patient participation in screening programs increases the need for imaging capacity and can encourage healthcare facilities to incorporate automated ultrasound systems into established breast cancer diagnostic workflows.

Advancements in wearable and AI-enabled breast imaging technologies improving diagnostic accuracy

Technological innovation is enhancing the capabilities of breast imaging through the integration of artificial intelligence, advanced sensors, and increasingly flexible imaging approaches. The automated breast ultrasound market is gaining from these developments as AI-enabled technologies can assist clinicians in interpreting images, identifying suspicious patterns, and reducing variability in image assessment. Wearable and compact imaging concepts may further support convenient monitoring and broaden the settings in which breast imaging can be performed, while automated image acquisition and intelligent analysis can improve workflow efficiency. These capabilities are particularly relevant for healthcare providers seeking diagnostic solutions that combine improved image interpretation with easier integration into modern screening and clinical environments.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising global breast cancer prevalence increasing demand for early-stage diagnostic imaging solutions 2.50% High North America, Asia Pacific High Near Term
Government awareness programs and cancer screening initiatives accelerating automated ultrasound adoption 2.10% High Asia Pacific, Europe High Mid Term
Advancements in wearable and AI-enabled breast imaging technologies improving diagnostic accuracy 1.80% High North America, Europe Emerging Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Automated Breast Ultrasound Market
Largest Region
North America
XX% Market Share in 2026

North America (Largest Region)

North America held the largest share of the automated breast ultrasound market in 2026, supported by advanced breast imaging infrastructure, widespread access to specialized diagnostic services, and strong emphasis on early detection of breast abnormalities. Healthcare providers are increasingly adopting automated ultrasound technologies to complement conventional imaging, particularly where improved breast tissue visualization is clinically valuable. Established reimbursement frameworks, growing awareness of breast cancer screening, and continued investment in diagnostic imaging capabilities further reinforce regional demand for automated and standardized ultrasound solutions.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, increasing awareness of breast cancer screening, and improving access to advanced diagnostic technologies. Rising healthcare expenditure and the modernization of hospitals and diagnostic centers are creating favorable conditions for the adoption of automated imaging systems. The growing need for efficient screening approaches in densely populated markets, combined with increasing clinical focus on earlier diagnosis, is expected to support broader utilization of automated breast ultrasound technologies across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Imaging Workflow Optimization

Germany is adopting automated breast ultrasound technologies to improve consistency and efficiency in breast imaging services. Healthcare institutions in Germany are evaluating systems that reduce operator dependency while supporting standardized diagnostic pathways.

France 🇫🇷

Structured Screening Support

France is focusing on technologies that complement established breast screening pathways and improve examination consistency. French healthcare providers are considering automated breast ultrasound solutions that enhance diagnostic confidence and streamline imaging workflows.

Italy 🇮🇹

Hospital Imaging Modernization

Italy's automated breast ultrasound market is supported by ongoing modernization of hospital imaging capabilities. Healthcare facilities in Italy are prioritizing systems that improve examination standardization and provide additional imaging options for complex breast assessments.

Japan 🇯🇵

Precision Diagnostic Integration

Japan emphasizes advanced imaging technologies that enhance diagnostic precision and support early cancer detection initiatives. Hospitals in Japan are incorporating automated breast ultrasound into broader imaging protocols, particularly where detailed breast assessments are required.

South Korea 🇰🇷

Technology-Enabled Screening Expansion

South Korea is investing in advanced diagnostic imaging platforms that improve patient access and screening efficiency. Medical centers in South Korea are increasingly evaluating automated breast ultrasound systems as part of comprehensive breast health programs.

United States 🇺🇸

Supplemental Screening Adoption

The U.S. market for automated breast ultrasound is driven by growing use of adjunct screening technologies for women with dense breast tissue. Healthcare providers in the U.S. are integrating automated systems to improve workflow efficiency and support earlier detection strategies.

Segment Analysis

Segment Leadership and Growth Trends

Automated Breast Ultrasound Market Share (%), by Product, 2026

Automated Breast Ultrasound (ABUS)
Automated Breast Volume Scanner

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Automated Breast Ultrasound (ABUS) (Largest Segment) vs Automated Breast Volume Scanner (Fastest-Growing Segment)

Automated breast ultrasound (ABUS) led the automated breast ultrasound market in 2026, capturing a 61.01% share, supported by its ability to provide standardized breast imaging while reducing dependence on continuous manual probe manipulation. Its suitability for supplemental breast examination, particularly where conventional imaging may have limitations, strengthens its role in diagnostic workflows. Automated acquisition and reproducible imaging also support efficient interpretation and integration into structured breast-screening practices.

The automated breast volume scanner segment is gaining momentum as healthcare providers seek volumetric breast imaging solutions that can improve visualization and support consistent examination workflows. Its ability to capture broader three-dimensional breast information can complement conventional imaging approaches, while growing emphasis on earlier detection and more comprehensive breast assessment is supporting adoption among diagnostic facilities.

End Use Segment Analysis: Hospital (Largest Segment) vs Diagnostics Imaging Laboratories (Fastest-Growing Segment)

Hospitals accounted for the largest share of the automated breast ultrasound market in 2026, representing 51.3%, due to their comprehensive diagnostic infrastructure, multidisciplinary clinical teams, and ability to manage patients across screening, diagnosis, treatment planning, and follow-up care. Automated breast ultrasound systems can be incorporated into established imaging departments, allowing hospitals to expand diagnostic capabilities while supporting coordinated breast-care pathways.

Diagnostics imaging laboratories are emerging as a rapidly expanding end-use setting as imaging services increasingly emphasize specialized, efficient, and patient-focused diagnostic workflows. These facilities can deploy automated ultrasound technologies to support standardized examinations and accommodate growing demand for breast imaging services, while their focus on diagnostic throughput and specialized imaging expertise strengthens the appeal of automated systems.

Segment Sub-Segment Largest Segment Fastest Growing
Product Automated Breast Volume Scanner, Automated Breast Ultrasound (ABUS) Automated Breast Ultrasound (ABUS) Automated Breast Volume Scanner
End Use Hospital, Diagnostics Imaging Laboratories, Others Hospital Diagnostics Imaging Laboratories
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the automated breast ultrasound market:

1. GE HealthCare Technologies Inc. (United States)

2. Koninklijke Philips N.V. (Netherlands)

3. Siemens Healthineers AG (Germany)

4. Canon Medical Systems Corporation (Japan)

5. Hologic Inc. (United States)

6. Delphinus Medical Technologies Inc. (United States)

7. SuperSonic Imagine SA (France)

8. TELEMED Medical Systems S.r.l. (Italy)

9. Samsung Medison Co. Ltd. (South Korea)

Advancements in diagnostic imaging technologies are strengthening the automated breast ultrasound market, with growing emphasis on improved image quality, workflow efficiency, and early disease detection. Regulatory support for advanced screening technologies is further encouraging wider clinical adoption and continued product innovation.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
GE HealthCare Technologies Inc. (United States)
Koninklijke Philips N.V. (Netherlands)
Siemens Healthineers AG (Germany)
Canon Medical Systems Corporation (Japan)
Hologic Inc. (United States)
Delphinus Medical Technologies Inc. (United States)
SuperSonic Imagine SA (France)
TELEMED Medical Systems S.r.l. (Italy)
Samsung Medison Co. Ltd. (South Korea).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
EndoCure Jan-26 EndoCure has developed a proprietary robotic imaging platform capable of generating high-density 3D images with precision surpassing conventional MRI technology. This innovation is strategically positioned to enhance diagnostic accuracy for oncology applications, representing a significant technological advancement in the automated breast imaging and diagnostic landscape.
Athens-Limestone Hospital Oct-25 Athens-Limestone Hospital deployed an FDA-approved automated breast ultrasound system to improve diagnostic efficacy for patients with dense breast tissue. This installation highlights the operational shift toward incorporating automated screening protocols in regional healthcare settings to increase the detection sensitivity for small-scale cancers and improve patient outcomes.
GE HealthCare Mar-25 GE HealthCare launched the Invenia ABUS Premium, an AI-enabled automated breast ultrasound system designed to optimize supplemental screening workflows. By integrating advanced imaging and automation, the system aims to improve diagnostic performance and operational efficiency in breast cancer detection, strengthening the company’s competitive position in the automated ultrasound market.
Hospital Universiti Sains Malaysia Oct-24 Hospital Universiti Sains Malaysia integrated the Invenia ABUS 2.0 system into its diagnostic suite, marking a strategic expansion of automated breast imaging technology in the region. This adoption enhances the facility's clinical capabilities for breast cancer detection and reflects the increasing global penetration of automated ultrasound systems in hospital networks.
Delphinus Medical Technologies, Inc. Jul-24 Delphinus Medical Technologies expanded the market footprint of its SoftVue 3D whole-breast ultrasound tomography system through a clinical implementation at West Jefferson Medical Center. This deployment demonstrates the ongoing commercial adoption of specialized breast ultrasound technology aimed at improving lesion detection in patients with dense breast tissue.
iSono Health May-22 iSono Health secured FDA clearance for its ATUSA system, a portable, automated breast imaging platform. This regulatory milestone enables the company to commercialize a specialized technology designed to improve accessibility and diagnostic outcomes in breast ultrasound screening, marking a significant entry of a new, distinct imaging capability into the market.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Automated Breast Ultrasound Market — Custom Segments

Segment Sub-Segment
Clinical Application Breast Cancer Screening, Diagnostic Evaluation, Supplemental Imaging, High-Risk Surveillance
Healthcare Facility Ownership Public/Government Facilities, Private Facilities, Non-Profit & Academic Facilities
Procurement Model Direct Capital Purchase, Leasing, Managed Equipment Services, Distributor/Third-Party Procurement

Automated Breast Ultrasound Market — Custom TOC

Custom Chapter Custom Details
Radiology AI Integration Opportunity Assessment
  • AI-Assisted Image Interpretation
  • Workflow Automation and Efficiency
  • Clinical Decision Support Integration
  • Diagnostic Consistency Enhancement
  • Future AI Innovation Roadmap
Screening Program Adoption Assessment
  • Population Screening Initiatives
  • Adoption Across Healthcare Systems
  • Clinical Implementation Drivers
  • Barriers to Large-Scale Deployment
Breast Imaging Workflow Optimization Assessment
  • Imaging Workflow Standardization
  • Resource Utilization and Throughput
  • Radiologist Productivity Enhancement
  • Patient Experience Improvements
  • Operational Best Practices
  • Future Workflow Evolution

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How much revenue does the automated breast ultrasound market generate?

The market revenue for automated breast ultrasound is anticipated at USD 2.88 billion in 2027.

How much is the automated breast ultrasound industry expected to grow by 2036?

Automated Breast Ultrasound Market size stood at USD 2.6 billion in 2026 and is predicted to grow at a 12.92% CAGR from 2027 to 2036, exceeding USD 8.76 billion by 2036.

How is rising breast cancer prevalence influencing demand for automated breast ultrasound systems?

Increasing breast cancer incidence is driving demand for early and consistent imaging, with automated systems enabling standardized acquisition, reduced operator dependence, and higher throughput, especially where dense breast tissue limits mammography effectiveness.

How are screening initiatives and AI advancements shaping adoption of automated breast ultrasound technologies?

Government screening programs expand imaging volumes and require scalable workflows, while AI-enabled systems improve lesion detection efficiency, reduce variability, and enhance radiologist productivity in high-demand diagnostic environments.

Why does ABUS remain the dominant product in the automated breast ultrasound market?

ABUS leads with 61.01% share due to strong clinical familiarity, integration into diagnostic workflows, and standardized imaging that reduces operator dependence in high-volume breast screening environments.

Why is the Automated Breast Volume Scanner segment growing faster than other technologies?

Automated Breast Volume Scanner is growing faster due to demand for more comprehensive volumetric breast imaging, offering detailed tissue visualization and aligning with efficient, structured diagnostic interpretation needs.

Why does North America lead the automated breast ultrasound market?

North America leads due to advanced breast imaging infrastructure, widespread diagnostic system availability, and routine integration of automated ultrasound into established clinical screening workflows.

What is driving Asia Pacific’s growth in this market?

Asia Pacific is expanding at 15.01% CAGR, driven by broader access to imaging systems and increasing adoption of scalable, workflow-efficient breast screening technologies across healthcare facilities.

What are the prominent companies operating in the automated breast ultrasound landscape?

Leading players in the automated breast ultrasound market include GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Hologic, Inc. (United States), Delphinus Medical Technologies, Inc. (United States), SuperSonic Imagine SA (France), TELEMED Medical Systems S.r.l. (Italy), Samsung Medison Co., Ltd. (South Korea).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →